Fair Phenotype Annotation and Genomic Reinterpretation
公平表型注释和基因组重新解释
基本信息
- 批准号:10675315
- 负责人:
- 金额:$ 88.64万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-07-01 至 2028-04-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAgeAlgorithmsAwarenessCase StudyCategoriesChildClinicalCodeDataDatabasesDevelopmentDiagnosisDiagnosticDiseaseDisparityDocumentationEffectivenessElectronic Health RecordEnsureEquityEvolutionFaceGene FrequencyGenesGeneticGenetic DiseasesGenomic medicineGenomicsGenotypeGoalsGrainHealthcareHealthcare SystemsIndividualInformaticsInstitutionKBG syndromeKnowledgeLaboratoriesLearningLiteratureManualsMedical RecordsMedical centerMethodologyMethodsNatural Language ProcessingNatural Language Processing pipelinePatientsPediatric HospitalsPerformancePhenotypePhiladelphiaPhysiciansPopulationPopulation HeterogeneityPublic HealthPublishingRare DiseasesResearchRetrievalSeveritiesSignal TransductionSourceSpecialistStructureSymptomsSyndromeTAF1 geneTestingTimeUnderrepresented PopulationsUnderserved PopulationUniversitiesVariantWalkingWorkWorld Healthclinical phenotypeclinical practiceclinical sequencingcomputable phenotypescostcost effectivenessdesigndigitaldisease phenotypeexomeexome sequencinggenetic disorder diagnosisgenetic variantgenome sequencinghealth disparityimprovedinnovationinsightinteroperabilityknowledge baseknowledge graphmultimodalitynovelopen source toolpatient populationphenomeportabilityprecision medicineroutine screeningtooltv watching
项目摘要
PROJECT SUMMARY
Given the rapid evolution of genomic knowledge, the need for genomic reinterpretation has been increasing.
However, there is no standard approach yet to identifying to whom, when, and how reinterpretation should be
provided to ensure accuracy, cost-effectiveness and fairness. Access to genomic tests and genetic specialists
has widened health disparities, which could be further exacerbated by limited ancestry-specific genetic data. Our
overarching goal is to design a scalable and sustainable informatics framework to support continuous genomic
reanalysis for symptomatic patients with non-diagnostic exome or genome sequencing in diverse populations.
Extending our prior published work on Doc2HPO, Criteria2Query, Phen2Gene, PhenCards, Phenominal, and
phenotype-disease knowledge graphs, we will first develop a natural language processing (NLP) pipeline to
create a multimodal phenome from clinical notes using the latest Phenopacket schema. By comparing changes
in longitudinal EHR phenotypes over time and analyzing the changes in the context of the new evidence for
variants, we will identify individuals who can benefit most from genomic reanalysis. Then we will incorporate
evolving clinical phenotypes extracted from longitudinal electronic health record (EHR) data to trigger automatic
variant reinterpretation using an ancestry-aware and age-sensitive knowledge graph (PhenoKG). Unlike typical
phenotype-based gene prioritization tools such as Phen2Gene, here we will build the knowledge graph by
extending our previous efforts and extracting phenotype-genotype relations from the EHR as well as the
literature. This knowledge graph will enable the query, extraction and inference of ancestry-aware, as well as
age-sensitive, phenotype-genotype relationships. By leveraging a multi-layer random-walk integrative network
approach, we will incorporate this heterogeneous knowledge graph into a phenotype-driven gene and variant
prioritization algorithm for continuous genomic reanalysis across diverse populations. With these methodological
developments, we will implement a routine reanalysis informatics pipeline at two academic institutions, Columbia
University Irving Medical Center (CUIMC) and Children’s Hospital of Philadelphia (CHOP). We will evaluate the
improvements in diagnostic yield across a diverse set of clinical exome/genome sequencing data over a 3-year
period. We will evaluate how our approach to fair phenotyping and continuous variant reinterpretation can reduce
genomic health disparities for underserved and underrepresented populations. Ultimately, these methods will
enable informatics-driven, efficient, scalable, continuous and fair genomic diagnostics for genomic medicine via
continuous genomic variant reinterpretation.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Wendy K Chung其他文献
Recent advances in understanding neurodevelopmental outcomes in congenital heart disease
先天性心脏病神经发育结局理解方面的最新进展
- DOI:
10.1016/j.gde.2022.101938 - 发表时间:
2022-08-01 - 期刊:
- 影响因子:3.600
- 作者:
Alban Ziegler;Wendy K Chung - 通讯作者:
Wendy K Chung
Wendy K Chung的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Wendy K Chung', 18)}}的其他基金
Prospective Genetic Risk Evaluation and Assessment (PROGRESS) in Autism
自闭症的前瞻性遗传风险评估(PROGRESS)
- 批准号:
10531728 - 财政年份:2022
- 资助金额:
$ 88.64万 - 项目类别:
Prospective Genetic Risk Evaluation and Assessment (PROGRESS) in Autism
自闭症的前瞻性遗传风险评估(PROGRESS)
- 批准号:
10698037 - 财政年份:2022
- 资助金额:
$ 88.64万 - 项目类别:
Project 1: Identifying and optimizing monogenetic risk prediction for autism in newborns
项目 1:识别和优化新生儿自闭症单基因风险预测
- 批准号:
10698081 - 财政年份:2022
- 资助金额:
$ 88.64万 - 项目类别:
Identifying and applying genetic variation relevant to clinical outcomes for individuals with congenital heart disease
识别和应用与先天性心脏病患者临床结果相关的遗传变异
- 批准号:
10028016 - 财政年份:2020
- 资助金额:
$ 88.64万 - 项目类别:
Role of the Kinesin KIF1A in Neurological Disease
驱动蛋白 KIF1A 在神经系统疾病中的作用
- 批准号:
10328907 - 财政年份:2020
- 资助金额:
$ 88.64万 - 项目类别:
Molecular Biology/Molecular Genetics (Core C)
分子生物学/分子遗传学(核心 C)
- 批准号:
9901512 - 财政年份:2020
- 资助金额:
$ 88.64万 - 项目类别:
Role of the Kinesin KIF1A in Neurological Disease
驱动蛋白 KIF1A 在神经系统疾病中的作用
- 批准号:
10543786 - 财政年份:2020
- 资助金额:
$ 88.64万 - 项目类别:
Identifying and applying genetic variation relevant to clinical outcomes for individuals with congenital heart disease
识别和应用与先天性心脏病患者临床结果相关的遗传变异
- 批准号:
10226278 - 财政年份:2020
- 资助金额:
$ 88.64万 - 项目类别:
Identifying and applying genetic variation relevant to clinical outcomes for individuals with congenital heart disease
识别和应用与先天性心脏病患者临床结果相关的遗传变异
- 批准号:
10460590 - 财政年份:2020
- 资助金额:
$ 88.64万 - 项目类别:
相似国自然基金
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
- 批准号:JCZRQN202500010
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
- 批准号:2025JJ70209
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
- 批准号:2023JJ50274
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
- 批准号:n/a
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
- 批准号:81973577
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
- 批准号:81602908
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
- 批准号:81501928
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
PROTEMO: Emotional Dynamics Of Protective Policies In An Age Of Insecurity
PROTEMO:不安全时代保护政策的情绪动态
- 批准号:
10108433 - 财政年份:2024
- 资助金额:
$ 88.64万 - 项目类别:
EU-Funded
The role of dietary and blood proteins in the prevention and development of major age-related diseases
膳食和血液蛋白在预防和发展主要与年龄相关的疾病中的作用
- 批准号:
MR/X032809/1 - 财政年份:2024
- 资助金额:
$ 88.64万 - 项目类别:
Fellowship
Atomic Anxiety in the New Nuclear Age: How Can Arms Control and Disarmament Reduce the Risk of Nuclear War?
新核时代的原子焦虑:军控与裁军如何降低核战争风险?
- 批准号:
MR/X034690/1 - 财政年份:2024
- 资助金额:
$ 88.64万 - 项目类别:
Fellowship
Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
- 批准号:
2341426 - 财政年份:2024
- 资助金额:
$ 88.64万 - 项目类别:
Continuing Grant
Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
- 批准号:
2341424 - 财政年份:2024
- 资助金额:
$ 88.64万 - 项目类别:
Continuing Grant
Doctoral Dissertation Research: Effects of age of acquisition in emerging sign languages
博士论文研究:新兴手语习得年龄的影响
- 批准号:
2335955 - 财政年份:2024
- 资助金额:
$ 88.64万 - 项目类别:
Standard Grant
The economics of (mis)information in the age of social media
社交媒体时代(错误)信息的经济学
- 批准号:
DP240103257 - 财政年份:2024
- 资助金额:
$ 88.64万 - 项目类别:
Discovery Projects
How age & sex impact the transcriptional control of mammalian muscle growth
你多大
- 批准号:
DP240100408 - 财政年份:2024
- 资助金额:
$ 88.64万 - 项目类别:
Discovery Projects
Supporting teachers and teaching in the age of Artificial Intelligence
支持人工智能时代的教师和教学
- 批准号:
DP240100111 - 财政年份:2024
- 资助金额:
$ 88.64万 - 项目类别:
Discovery Projects
Enhancing Wahkohtowin (Kinship beyond the immediate family) Community-based models of care to reach and support Indigenous and racialized women of reproductive age and pregnant women in Canada for the prevention of congenital syphilis
加强 Wahkohtowin(直系亲属以外的亲属关系)以社区为基础的护理模式,以接触和支持加拿大的土著和种族育龄妇女以及孕妇,预防先天梅毒
- 批准号:
502786 - 财政年份:2024
- 资助金额:
$ 88.64万 - 项目类别:
Directed Grant